DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Celgene (NASDAQ: CELG)

97.89 -4.04 (-3.96%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $97.89 -3.96%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.72
Previous Close $101.93
Daily Range $96.40 - $101.94
52-Week Range $92.98 - $140.72
Market Cap $76.9B
P/E Ratio 21.64
Dividend (Yield) $0.00 (0.0%)
Volume 7,801,969
Average Daily Volume 7,286,012
Current FY EPS $4.19




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

The Silly Reason Why Agios Pharmaceuticals Inc. Was Clobbered in January

Agios Pharmaceuticals actually delivered an encouraging strategic outline at the J.P. Morgan Healthcare Conference, but wound up being derailed by investor sentiment.

ImmunoGen/Merck Collaborate for Ovarian Cancer Study

Leerink Is Back On Board The Biotech Train

See Which Of The Latest 13F Filers Holds Celgene

Why Did Biotech Fall Off a Cliff in January?

Biotech's decline doesn't signal the start of a bear market for the industry. Here's why.

Synthetic Biologics Tanks on Unfavorable Trimesta Data

Alexion Misses on Earnings and Revenues in Q4, Gives View

Avalanche (AAVL) Set to Acquire Annapurna Therapeutics

Exelixis' Cabozantinib Positive in Renal Cell Carcinoma Study

Why NantKwest Shares Fell 41% in January

Billionaire Patrick Soon-Shiong hopes to change cancer treatment forever.

See More CELG News...

CELG's Top Competitors

CELG $97.89 (-3.96%)
Current stock: CELG
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
$0.00 (0.00%)
Current stock: